Latest news

RCPharm tightens guidance on aesthetic practice

FDA approves HA filler portfolio

Abstracts: A Summary of the Latest Clinical Studies

Optimising Pre- and Post-Procedural Skincare

Wigmore Medical appointed as pharmacy partner for AQ Skin Solutions

Advertorial: One patient record. One clearer prescribing workflow.

Dermalogica PRO appoints MedFx as UK supplier

DermaFocus unveils global expansion

Australian Government updates packaging rules

Treating Hyperpigmentation with Topicals

Understanding Gynaecomastia

Published

September 7, 2021

Written by...

Kate Byng-Hall

Share this article

Mr Alex Karidis outlines the causes of gynaecomastia and his approach to treatment

Subscriber content

Continue reading this clinical article

To read this post in full you need an Aesthetics Journal subscription. Choose the plan that fits your practice — every paid plan includes the complete peer-reviewed clinical library and CPD-accredited learning.

Join

Already a subscriber? Log in

Quick links

Wigmore Medical appointed as pharmacy partner for AQ Skin Solutions

September 18, 2026

Nordberg Medical gains EU Medical Device Regulation certification

September 16, 2026

Combining Topical Regenerative Therapy with Microneedling

September 14, 2026

Fotona appoints CPO

September 11, 2026

CPD: Understanding Peptides

September 10, 2026